clinical Targets
Select from our list of proposed clinical targets and custom assays utilizing them for analyzing and manipulating protein function.
Modified cells
Use our screening service to validate your compound or target candidates in cells modified with our bioactive peptides for knock in/out .
PTM
Choose from our catalog of >5,000 post translationally modified proteins for use in your drug discovery research or compound screening.
Degrader function
Access our custom assay service for safety assessment of cereblon natural substrates or Neosubstrate discovery in presence of iMiDs or PROTACs.
Discover Our Comprehensive List of Products & Services
Harness the potential of our insights, tools, and professional team to accelerate your drug discovery programs with small molecule or degrader compositions.
Cereblon is a Multifunctional Protein
A workhorse enzyme harnessed in degrader technologies, recent work from VistaraBio and others has uncovered new roles for it, suggesting novel therapeutic applications.
PTMs will Revolutionize Drug Discovery
Most clinically relevant proteins are subject to PTMs. Emerging studies from VistaraBio have identified PTMs and methods to overproduce them in human cells for applications in drug discovery.
Cell Modification & Peptide Therapeutics
VistaraBio is employing bioactive peptide expression for modifying cells in vitro. The null phenotypes are invaluable for validating targets and therapeutic candidates.